Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity

Journal of Medical Virology

Volumn 61, Issue 4, 2000, Pages 497-503

  Gomi, Yasuyuki ^a   Imagawa, Tadashi ^a   Takahashi, Michiaki ^b   Yamanishi, Koichi ^c  

^a Res Found Microbial Dis Osaka U   (Japan)

^b Osaka University   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Attenuation; IE62; Transactivation; Vaccine; Varicella zoster virus

Indexed keywords

CHICKENPOX VACCINE; PROTEIN C; TRANSACTIVATOR PROTEIN; VIRUS DNA; VIRUS GLYCOPROTEIN;

ARTICLE; DNA SEQUENCE; DRUG STRUCTURE; GENE CONTROL; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MOLECULAR CLONING; OPEN READING FRAME; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; TRANSACTIVATION; VARICELLA ZOSTER VIRUS; VIRUS ATTENUATION;

CELLS, CULTURED; CHICKENPOX VACCINE; DNA PRIMERS; GENES, IMMEDIATE-EARLY; GLYCOPROTEINS; HERPESVIRUS 3, HUMAN; HUMANS; MUTATION; OPEN READING FRAMES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANSFECTION; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS;

EID: 0033923798     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200008)61:4<497::AID-JMV13>3.0.CO;2-2     Document Type: Article

References (20)

1. Baudoux L, Defechereux P, Schoonbroodt S, Merville MP, Rentier B, Piette J. 1995. Mutational analysis of varicella-zoster virus major immediate-early protein IE62. Nucleic Acids Res 23:1341-1349.
2. Cohen JI, Seidel KE. 1993.Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc Natl Acad Sci USA 90:7376-7380.
3. Davison AJ, Scott JE. 1986. The complete DNA sequence of varicella-zoster virus. J Gen Virol 67:1759-1816.
4. Defechereux P, Melen L, Baudoux L, Merville Louis MP, Rentier B, Piette J. 1993. Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J Virol 67: 4379-4385.
5. Defechereux P, Debrus S, Baudoux L, Schoonbroodt S, Merville MP, Rentier B, Piette J. 1996. Intracellular distribution of the ORF4 gene product of varicella-zoster virus is influenced by the IE62 protein. J Gen Virol 77:1505-1513.
6. Gelb LD, Dohner DE, Gershon AA, Steinberg SP, Waner JL, Takahashi M, Dennehy PH, Brown AE. 1987. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults. J Infect Dis 155:633-640.
7. Hayakawa Y, Yamamoto T, Yamanishi K, Takahashi M. 1986. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease Hpa I. J Gen Virol 67:1817-1829.
8. Inchauspe G, Nagpal S, Ostrove JM. 1989. Mapping of two varicella-zoster virus-encoded genes that activate the expression of viral early and late genes. Virology 173:700-709.
9. Kinchington PR, Ling P, Pensiero M, Gershon A, Hay J, Ruyechan WT. 1990. A possible role for glycoprotein gpV in the pathogenesis of varicella-zoster virus. Adv Exp Med Biol 278:83-91.
10. Kinchington PR, Hougland K, Arvin AM, Ruyechan WT, Hay J. 1992. The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol 66:359-366.
11. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. 1992. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 66:1016-1020.
12. Ling P, Kinchington PR, Ruyechan WT, Hay J. 1991. A detailed analysis of transcripts mapping to varicella zoster virus gene 14 (glycoprotein V). Virology 184:625-635.
13. Ling P, Kinchington PR, Sadeghi-Zadeh M, Ruyechan WT, Hay J. 1992. Transcription from varicella-zoster virus gene 67 (glycoprotein IV). J Virol 66:3690-3698.
14. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM. 1998. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72:965-974.
15. Mori C, Takahara R, Toriyama T, Nagai T, Takahashi M, Yamanishi K. 1998. Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J Infect Dis 178:35-38.
16. Moriuchi H, Moriuchi M, Cohen JI. 1995. Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein. J Virol 69:4693-4701.
17. Moriuchi M, Moriuchi H, Straus SE, Cohen JI. 1994. Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology 200: 297-300.
18. Perera LP, Mosca JD, Ruyechan WT, Hay J. 1992. Regulation of varicella-zoster virus gene expression in human T lymphocytes. J Virol 66:5298-5304.
19. Schoonbroodt S, Piette J, Baudoux L, Defechereux P, Rentier B, Merville MP. 1996. Enhancement of varicella-zoster virus infection in cell lines expressing ORF4-or ORF62-encoded proteins. J Med Virol 49:264-273.
20. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. 1974. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2:1288-1290.